Anavex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
AVXL Key Statistics
Stock Snapshot
Anavex(AVXL) stock is priced at $4.33, giving the company a market capitalization of 381.07M. It carries a P/E multiple of -7.85.
As of 2026-01-08, Anavex(AVXL) stock has fluctuated between $3.95 and $4.35. The current price stands at $4.33, placing the stock +9.6% above today's low and -0.5% off the high.
The Anavex(AVXL)'s current trading volume is 1.27M, compared to an average daily volume of 1.94M.
In the last year, Anavex(AVXL) shares hit a 52-week high of $13.99 and a 52-week low of $2.86.
In the last year, Anavex(AVXL) shares hit a 52-week high of $13.99 and a 52-week low of $2.86.
AVXL News
Anavex Life Sciences (AVXL) announced the appointment of Wolfgang Liedtke, MD PhD, as Senior Vice President, Global Head of Neurology. Liedtke is a board-certif...
Anavex (AVXL) Life Sciences announced that the U.S. Food and Drug Administration had invited the Company to present the Company’s Alzheimer’s disease clinical t...